Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,500 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 July 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 206 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 18 results:
Author Title [ Type(Desc)] Year
Filters: Author is Ernst, P.  [Clear All Filters]
Journal Article
B. M. Hicks, Yin, H., Bladou, F., Ernst, P., and Azoulay, L., Androgen deprivation therapy for prostate cancer and the risk of hospitalisation for community-acquired pneumonia, Thorax, vol. 72, pp. 596-597, 2017.
F. Giorgianni, Ernst, P., Dell'Aniello, S., Suissa, S., and Renoux, C., Beta 2 agonists and the incidence of Parkinson's disease, Am J Epidemiol, 2020.
S. Suissa, Dell'Aniello, S., and Ernst, P., Comparative effectiveness and safety of LABA-LAMA versus LABA-ICS treatment of COPD in real world clinical practice, Chest, 2019.
S. Suissa, Dell'Aniello, S., and Ernst, P., Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study, Lancet Respir Med, vol. 6, pp. 855-862, 2018.
S. Suissa, Dell'Aniello, S., and Ernst, P., Comparative effects of LAMA-LABA-ICS versus LAMA-LABA for COPD: Cohort study in real world clinical practice: LAMA-LABA-ICS versus LAMA-LABA in COPD, Chest, 2019.
S. Suissa, Dell'Aniello, S., and Ernst, P., Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events, Eur Respir J, vol. 49, 2017.
J. L. Faillie, Filion, K. B., Patenaude, V., Ernst, P., and Azoulay, L., Dipeptidyl peptidase-4 inhibitors and the risk of community-acquired pneumonia in patients with type 2 diabetes, Diabetes Obes Metab, vol. 17, pp. 379-85, 2015.
P. Brassard, Wu, J. W., Ernst, P., Dell'Aniello, S., Smiechowski, B., and Suissa, S., The effect of statins on influenza-like illness morbidity and mortality, Pharmacoepidemiol Drug Saf, vol. 26, pp. 63-70, 2017.
K. B. Filion, Delaney, J. A., Brophy, J. M., Ernst, P., and Suissa, S., The impact of over-the-counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research Database, Pharmacoepidemiol Drug Saf, vol. 16, pp. 1-4, 2007.
S. Suissa, Dell'Aniello, S., and Ernst, P., Long-Acting Bronchodilator Initiation in COPD and the Risk of Adverse Cardiopulmonary Events: A Population-Based Comparative Safety Study, Chest, vol. 151, pp. 60-67, 2017.
K. B. Filion, Azoulay, L., Platt, R. W., Dahl, M., Dormuth, C. R., Clemens, K. K., Hu, N., Paterson, J. M., Targownik, L., Turin, T. C., Udell, J. A., and Ernst, P., A Multicenter Observational Study of Incretin-based Drugs and Heart Failure, N Engl J Med, vol. 374, pp. 1145-54, 2016.
P. Ernst, Renoux, C., Dell'Aniello, S., and Suissa, S., Pramipexole use and the risk of pneumonia, BMC Neurol, vol. 12, p. 113, 2012.
K. B. Filion, Chateau, D., Targownik, L. E., Gershon, A., Durand, M., Tamim, H., Teare, G. F., Ravani, P., Ernst, P., and Dormuth, C. R., Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis, Gut, vol. 63, pp. 552-8, 2014.
P. Ernst, Dell'Aniello, S., Mikaeloff, Y., and Suissa, S., Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study, BMC Pulm Med, vol. 11, p. 59, 2011.
C. Renoux, Lix, L. M., Patenaude, V., Bresee, L. C., Paterson, J. M., Lafrance, J. P., Tamim, H., Mahmud, S. M., Alsabbagh, M. W., Hemmelgarn, B., Dormuth, C. R., and Ernst, P., Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis, Clin J Am Soc Nephrol, vol. 10, pp. 1716-22, 2015.
J. Y. Shin, Eberg, M., Ernst, P., and Filion, K. B., Statin potency and the risk of hospitalization for community-acquired pneumonia, Br J Clin Pharmacol, vol. 83, pp. 1319-1327, 2017.
C. R. Dormuth, Hemmelgarn, B. R., Paterson, J. M., James, M. T., Teare, G. F., Raymond, C. B., Lafrance, J. P., Levy, A., Garg, A. X., and Ernst, P., Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases, Bmj, vol. 346, p. f880, 2013.
C. Renoux, Dell'Aniello, S., Khairy, P., Marras, C., Bugden, S., Turin, T. C., Blais, L., Tamim, H., Evans, C., Steele, R., Dormuth, C., and Ernst, P., Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease, Br J Clin Pharmacol, vol. 82, pp. 461-72, 2016.
[Page last reviewed 6 July 2020]